COVID-19 rapid guideline: managing the long-term effects of COVID-19

Supporting evidence

• Evidence review

• Evidence review A: risk factors (PDF 646 KB)

  Published:

  25 January 2024

• Evidence review B: Prevalence (PDF 1.07 MB)

  Published:

  25 January 2024

• Evidence review C: investigations (PDF 818 KB)

  Published:

  25 January 2024

• Evidence review D: interventions (PDF 313 KB)

  Published:

  25 January 2024

• Evidence review E: monitoring and referral (PDF 391 KB)

  Published:

  25 January 2024

• Evidence review F: service organisation (PDF 508 KB)

  Published:

  25 January 2024

• Evidence review G: risk factors (update) (PDF 635 KB)

  Published:

  25 January 2024

• Evidence review H: case definition (PDF 645 KB)

  Published:

  25 January 2024

• Evidence review I: signs and symptoms (update) (PDF 790 KB)

  Published:

  25 January 2024

• Evidence review J: children and young people (PDF 1.27 MB)

  Published:

  25 January 2024

• Evidence reviews K: impact of vaccines (update) (PDF 2.95 MB)

  Published:

  25 January 2024

• Evidence review: Case definition (PDF 561 KB)

  Published:

  25 January 2024

• Evidence review: The views and experiences of patients, their families and carers  (PDF 1.07 MB)

  Published:

  25 January 2024

• Evidence review: Barriers to and the facilitators of, timely referral to specialist care (PDF 615 KB)

  Published:

  25 January 2024

• Supporting document 1: Excluded studies report for evidence reviews A to F (PDF 598 KB)

  Published:

  25 January 2024

• Supporting document 2: Expert testimony for rehabilitation (PDF 356 KB)

  Published:

  25 January 2024

• Methods: Chapter 1 (PDF 181 KB)

  Published:

  25 January 2024

• Methods: Chapter 2 (PDF 202 KB)

  Published:

  25 January 2024

• Other supporting evidence

• Original development - December 2020

• Methods (PDF 122 KB)

  Published:

  18 December 2020

• Search strategies (PDF 1016 KB)

  Published:

  18 December 2020